Skip to main content

Table 1 Inhibitors of cell cytoskeleton used in the study

From: Neurons cytoskeletal architecture remodeling during the replication cycle of mouse coronavirus MHV-JHM: a morphological in vitro study

Substance

Form

Therapeutic effect/treatment

Nocodazole

benzimidazole substituted at position 2 by a (methoxycarbonyl)amino group and at position 5 by a 2-thienoyl group

antineoplastic agent, a tubulin modulator, an antimitotic, and a microtubule-destabilizing agent and an inhibitor of various cancer-related kinases.

Noscapine

phthalide isoquinoline alkaloid from Papaver somniferum

analgesic, antitussive, disruption of the dynamics of microtubule assembly, the inhibition of mitosis and tumor cell death, noscapine does not affect microtubule polymerization, antiviral activity by inhibition of Mpro protease.

Paclitaxel

a tetracyclic diterpenoid from the bark of the Taxus brevifolia

a mitotic inhibitor used in cancer chemotherapy, an antineoplastic agent, a microtubule-stabilizing agent, and an antineoplastic agent.

Latrunculin A

16-membered bicyclic lactone attached to the rare 2-thiazolidinone moiety from Latrunculia magnifica

impacts actin polymerization, microfilament organization, and microfilament-mediated processes.

Cytochalasin D

cell-permeable fungal toxin; from Zygosporium mansonii

potent inhibitor of actin polymerization; disrupts actin microfilaments; activates the p53-dependent pathways; inhibits smooth muscle contraction.